The Struengmann Family Office, managed by the billionaire twins Thomas and Andreas Strüngmann, is a prominent investment entity known for its significant investments in the healthcare and biotechnology sectors. They are notably early backers of BioNTech, a company that gained global recognition for its COVID-19 vaccine developed in partnership with Pfizer. The family office operates under the name Athos KG and manages a substantial fortune, focusing on innovative ventures in health and medicine.
Focus Areas
Notable Investments
